Paul Dunkow Orthopaedics Limited 12468664 false 2024-03-01 2025-02-28 2025-02-28 The principal activity of the company is orthopaedics. Digita Accounts Production Advanced 6.30.9574.0 true true 12468664 2024-03-01 2025-02-28 12468664 2025-02-28 12468664 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-02-28 12468664 core:RetainedEarningsAccumulatedLosses 2025-02-28 12468664 core:ShareCapital 2025-02-28 12468664 core:CurrentFinancialInstruments 2025-02-28 12468664 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 12468664 core:FurnitureFittingsToolsEquipment 2025-02-28 12468664 core:OtherPropertyPlantEquipment 2025-02-28 12468664 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2025-02-28 12468664 bus:SmallEntities 2024-03-01 2025-02-28 12468664 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 12468664 bus:FilletedAccounts 2024-03-01 2025-02-28 12468664 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 12468664 bus:RegisteredOffice 2024-03-01 2025-02-28 12468664 bus:Director1 2024-03-01 2025-02-28 12468664 bus:Director2 2024-03-01 2025-02-28 12468664 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-03-01 2025-02-28 12468664 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 12468664 bus:Agent1 2024-03-01 2025-02-28 12468664 core:FurnitureFittings 2024-03-01 2025-02-28 12468664 core:FurnitureFittingsToolsEquipment 2024-03-01 2025-02-28 12468664 core:OfficeEquipment 2024-03-01 2025-02-28 12468664 core:OtherPropertyPlantEquipment 2024-03-01 2025-02-28 12468664 core:PlantMachinery 2024-03-01 2025-02-28 12468664 core:KeyManagementPersonnel 2024-03-01 2025-02-28 12468664 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-03-01 2025-02-28 12468664 countries:EnglandWales 2024-03-01 2025-02-28 12468664 2024-02-29 12468664 core:FurnitureFittingsToolsEquipment 2024-02-29 12468664 core:OtherPropertyPlantEquipment 2024-02-29 12468664 2023-03-01 2024-02-29 12468664 2024-02-29 12468664 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-02-29 12468664 core:RetainedEarningsAccumulatedLosses 2024-02-29 12468664 core:ShareCapital 2024-02-29 12468664 core:CurrentFinancialInstruments 2024-02-29 12468664 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 12468664 core:FurnitureFittingsToolsEquipment 2024-02-29 12468664 core:OtherPropertyPlantEquipment 2024-02-29 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12468664

Paul Dunkow Orthopaedics Limited

Unaudited Filleted Financial Statements

for the Year Ended 28 February 2025

 

Paul Dunkow Orthopaedics Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 9

 

Paul Dunkow Orthopaedics Limited

Company Information

Directors

Mr P Dunkow

Dr M A Dunkow

Registered office

Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF

Accountants

Crossley & Davis Chartered Accountants
Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Paul Dunkow Orthopaedics Limited
for the Year Ended 28 February 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Paul Dunkow Orthopaedics Limited for the year ended 28 February 2025 as set out on pages 3 to 9 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Paul Dunkow Orthopaedics Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Paul Dunkow Orthopaedics Limited and state those matters that we have agreed to state to the Board of Directors of Paul Dunkow Orthopaedics Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Paul Dunkow Orthopaedics Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Paul Dunkow Orthopaedics Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Paul Dunkow Orthopaedics Limited. You consider that Paul Dunkow Orthopaedics Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Paul Dunkow Orthopaedics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Crossley & Davis Chartered Accountants
Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF

1 December 2025

 

Paul Dunkow Orthopaedics Limited

(Registration number: 12468664)
Balance Sheet as at 28 February 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

8,859

11,028

Current assets

 

Debtors

5

497,272

307,605

Cash at bank and in hand

 

1,633,977

1,269,008

 

2,131,249

1,576,613

Creditors: Amounts falling due within one year

6

(198,205)

(163,440)

Net current assets

 

1,933,044

1,413,173

Total assets less current liabilities

 

1,941,903

1,424,201

Provisions for liabilities

(2,215)

(2,757)

Net assets

 

1,939,688

1,421,444

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

1,939,588

1,421,344

Shareholders' funds

 

1,939,688

1,421,444

For the financial year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 1 December 2025 and signed on its behalf by:
 

 

Paul Dunkow Orthopaedics Limited

(Registration number: 12468664)
Balance Sheet as at 28 February 2025

.........................................
Mr P Dunkow
Director

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF
England

These financial statements were authorised for issue by the Board on 1 December 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant & machinery

20% straight line

Fixtures and fittings

25% straight line

Office equipment

20% straght line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 5 (2024 - 5).

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Other property, plant and equipment
 £

Total
£

Cost or valuation

At 1 March 2024

13,439

2,796

16,235

Additions

1,253

-

1,253

At 28 February 2025

14,692

2,796

17,488

Depreciation

At 1 March 2024

4,974

233

5,207

Charge for the year

2,863

559

3,422

At 28 February 2025

7,837

792

8,629

Carrying amount

At 28 February 2025

6,855

2,004

8,859

At 29 February 2024

8,465

2,563

11,028

5

Debtors

Current

2025
£

2024
£

Trade debtors

348,179

291,017

Prepayments

16,824

16,588

Other debtors

132,269

-

 

497,272

307,605

6

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Trade creditors

-

14,400

Taxation and social security

191,717

140,348

Accruals and deferred income

5,750

2,750

Other creditors

738

5,942

198,205

163,440

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2025

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary share capital of £1 each

100

100

100

100

       

8

Related party transactions

Loans to related parties

2025

Key management
£

Total
£

Advanced

82,721

82,721

At end of period

82,721

82,721

Terms of loans to related parties

Loans to directors are unsecured, repayable on demand, and interest is charged at the official rate on any balance that exceeds £10,000 throughout the year.